National Lung Cancer Audit (NLCA) blog

This blog has been created to keep lung cancer teams up to date with the latest news and key issues affecting the NLCA or mesothelioma audit, including quality improvement (QI) initiatives and data collection methodology.

What we are doing

The posts will be written regularly by the National Lung Cancer Audit (NLCA) team and wider stakeholders from the lung cancer community. 

To subscribe, or if you have any questions or comments in response to the blog, please email

What we have produced

Neal Navani, clinical lead at the National Lung Cancer Audit (NLCA), explains why we are running our spotlight audit of patients who were diagnosed in 2015 with early-stage disease and good performance status bu

NLCA senior clinical lead Paul Beckett outlines the audit's plans to implement a local validation process in England to quality assure the registry data before publication of our next report.

National Lung Cancer Audit (NLCA) clinical lead Susan Harden writes about her quality improvement visit to the North West.
With the National Lung Cancer Audit (NLCA) about to embark on the second national organisational audit Dr Bhavani Adizie asks 'what is this audit' and 'why is it so important'?
Tasha Wood, audit project manager at National Cancer Registration and Analysis Service (NCRAS), outlines how to obtain the patient-level data behind the National Lung Cancer Audit (NLCA) annual report.

NLCA clinical lead Paul Beckett discusses his quality improvement (QI) visit to the North West.

Liz Darlison, director of services at Mesothelioma UK, discusses the importance of the national mesothelioma audit.

Ian Woolhouse, senior clinical lead for the National Lung Cancer Audit (NLCA), discusses the use of clinical indicators in the audit. 

In January 2017, the National Lung Cancer Audit (NLCA) will publish its first annual report based on data sourced from the National Cancer Registration and Analysis Service (NCRAS).